Short-term disability in solid tumor patients with bone metastases and skeletal-related events

References

• Coleman RE. Bisphosphonates: clinical experience. Oncologist 2004;9(4 Suppl):14-27
   PubMed Web of Science ®Google Scholar
• Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243s-9s
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-93
   PubMed Web of Science ®Google Scholar
• Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350:1655-64
   PubMed Web of Science ®Google Scholar
• Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997;69:1-18
   PubMed Web of Science ®Google Scholar
• Ripamonti C, Fulfaro F. Pathogenesis and pharmacological treatment of bone pain in skeletal metastases. Q J Nucl Med 2001;45:65-77
   PubMedGoogle Scholar
• Berruti A, Tucci M, Mosca A, et al. Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. Br J Cancer 2005;93:633-8
   PubMed Web of Science ®Google Scholar
• Jonler M, Nielsen OS, Groenvold M, et al. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5. Scand J Urol Nephrol 2005;39:42-8
   PubMed Web of Science ®Google Scholar
• Lipton A, Theriault RL, Hortobagyi GN, et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 2000;88:1082-90
   PubMed Web of Science ®Google Scholar
• Saad F, Gleason DM, Murray R, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 2002;94:1458-68
   PubMed Web of Science ®Google Scholar
• Saad F, Gleason DM, Murray R, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2004;96:879-82
   PubMed Web of Science ®Google Scholar
• Arellano J, Chen K, Halperin M, et al. Skeletal-related events (SRE) prevented in breast cancer patients with bone metastases in the United States (US) (poster presentation at 2013 San Antonio Breast Cancer Symposium). Cancer Res 2013;73(24 Suppl):abstract P1-16-01
   Google Scholar
• Weinfurt KP, Li Y, Castel LD, et al. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol 2005;16:579-84
   PubMed Web of Science ®Google Scholar
• Coleman RE. Skeletal complications of malignancy. Cancer 1997;80:1588-94
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Oglesby A, Chung K, et al. The impact of bone metastases and skeletal-related events on healthcare costs in prostate cancer patients receiving hormonal therapy. Commun Oncol 2011;8:508-15
   Google Scholar
• Delea T, McKiernan J, Brandman J, et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol 2006;4:341-7
   PubMedGoogle Scholar
• Delea TE, McKiernan J, Brandman J, et al. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol 2006;1:571-6
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Delea TE, Saville MW, et al. Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis 2013;16:23-7
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Chung K, Delea TE. Health care utilization and costs associated with skeletal-related events (SREs) in patients with breast cancer (BC) and bone metastases (BMets) (poster presentation at 2012 Breast Cancer Symposium). J Clin Oncol 2012;30(Suppl 27):abstract 72
   Google Scholar
• Insure.com. The basics of short-term disability insurance. 2010. http://www.insure.com/articles/disabilityinsurance/short-term-disability.html. Accessed January 22, 2014
   Google Scholar
• Bureau of Labor Statistics. Employee benefits survey - short-term disability plans: fixed percent of annual earnings. 2012. Washington, DC: US Bureau of Labor Statistics. http://www.bls.gov/ncs/ebs/benefits/2012/ownership/private/table36a.htm. Accessed January 22, 2014
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Ashenfelter O, Card D. Using the longitudinal structure of earnings to estimate the effect of training programs. Rev Econ Stat 1985;67:648-60
   Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts & Figures 2014. Available from: https://doi.org/http://www.cancer.org/cancer/cancerbasics/economic-impact-of-cancer. Accessed August 29, 2014
   Google Scholar
• Schultz AB, Chen CY, Edington DW. The cost and impact of health conditions on presenteeism to employers: a review of the literature. Pharmacoeconomics 2009;27:365-78
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Leal J, Gray A, et al. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013;14:1165-74
   PubMed Web of Science ®Google Scholar
• Mujahid MS, Janz NK, Hawley ST, et al. The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 2010;119:213-20
   PubMed Web of Science ®Google Scholar
• Wan Y, Gao X, Mehta S, et al. Indirect costs associated with metastatic breast cancer. J Med Econ 2013;16:1169-78
   PubMedGoogle Scholar
• Lidgren M, Wilking N, Jonsson B, et al. Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care 2007;23:223-31
   PubMed Web of Science ®Google Scholar
• Bureau of Labor Statistics. Economic news release - private industry, by establishment size. 2012. Washington, DC: US Bureau of Labor Statistics, http://www.bls.gov/news.release/ecec.t08.htm. Accessed January 22, 2014
   Google Scholar